• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝移植前肾功能障碍与移植后终末期肾病的关系:UNOS 最新建议的单中心检查。

Pre-liver transplant renal dysfunction and association with post-transplant end-stage renal disease: A single-center examination of updated UNOS recommendations.

机构信息

Recanati Miller Transplant Institute, Icahn School of Medicine at Mount Sinai, New York City, New York.

出版信息

Clin Transplant. 2018 Dec;32(12):e13428. doi: 10.1111/ctr.13428. Epub 2018 Dec 14.

DOI:10.1111/ctr.13428
PMID:30338873
Abstract

Simultaneous liver-kidney allocation protocols allocate dual organs based on a sustained eGFR of 30 mL/min or less. A 2017-UNOS update includes CKD3 as dual organ candidates but only when the listing eGFR is <30 mL/min while recommending a "safety net" for prioritized kidney listing post-LT. We retrospectively reviewed adult LTs examine whether the UNOS proposal captured the LT population at highest risk for developing post-LT ESRD. Among 290 LT recipients, 67 had pre-LT CKD3, 141 had AKI, of whom 47 required dialysis (<4 weeks). During follow-up, 25 (8.62%) developed ESRD, while 70 (24.1%) died. In adjusted Cox models, CKD3 had an independent association with post-LT ESRD (adjusted HR 4.8; P = 0.001), independent of AKI. Interestingly, CKD3 with listing GFR >30 mL/min was still significantly associated with post-LT ESRD. AKI was associated with reduced post-LT survival (adjusted HR 1.9; P = 0.02), albeit only in the first-year post-LT. Severe AKI-D was associated with post-LT ESRD and mortality. The safety net would have captured only 60% of all post-LT ESRD cases in our cohort. Pre-LT CKD3 was associated with increased risk of post-LT ESRD above the recommended cutoff for listing GFR. These findings, if generalizable in larger cohorts have important implications for dual organ allocation.

摘要

同时进行肝和肾分配的协议是基于持续的 eGFR 为 30ml/min 或更低来分配双器官。2017 年 UNOS 更新包括 CKD3 作为双器官候选者,但仅当列入 eGFR 小于 30ml/min 时,同时建议在 LT 后为优先肾列入设置"安全网"。我们回顾性研究了成人 LT,检查 UNOS 建议是否涵盖了 LT 人群中发生 LT 后 ESRD 风险最高的人群。在 290 名 LT 受者中,有 67 人有 LT 前 CKD3,141 人有 AKI,其中 47 人需要透析(<4 周)。在随访期间,25 人(8.62%)发生 ESRD,70 人(24.1%)死亡。在调整后的 Cox 模型中,CKD3 与 LT 后 ESRD 有独立关联(调整后的 HR 4.8;P=0.001),独立于 AKI。有趣的是,即使列入 GFR>30ml/min,CKD3 仍与 LT 后 ESRD 显著相关。AKI 与 LT 后生存率降低相关(调整后的 HR 1.9;P=0.02),尽管仅在 LT 后第一年。严重的 AKI-D 与 LT 后 ESRD 和死亡率相关。安全网在我们的队列中只能捕获所有 LT 后 ESRD 病例的 60%。LT 前 CKD3 与 LT 后 ESRD 风险增加相关,超过列入 GFR 的建议截止值。如果这些发现可以在更大的队列中得到验证,那么它们对双器官分配具有重要意义。

相似文献

1
Pre-liver transplant renal dysfunction and association with post-transplant end-stage renal disease: A single-center examination of updated UNOS recommendations.肝移植前肾功能障碍与移植后终末期肾病的关系:UNOS 最新建议的单中心检查。
Clin Transplant. 2018 Dec;32(12):e13428. doi: 10.1111/ctr.13428. Epub 2018 Dec 14.
2
The liver recipient with acute renal dysfunction: A single institution evaluation of the simultaneous liver-kidney transplant candidate.伴有急性肾功能不全的肝移植受者:单中心对肝肾联合移植候选者的评估
Clin Transplant. 2018 Jan;32(1). doi: 10.1111/ctr.13148. Epub 2017 Nov 24.
3
Early Allograft Dysfunction After Liver Transplantation Is Associated With Short- and Long-Term Kidney Function Impairment.肝移植后早期移植物功能障碍与短期和长期肾功能损害有关。
Am J Transplant. 2016 Mar;16(3):850-9. doi: 10.1111/ajt.13527. Epub 2015 Dec 11.
4
Renal outcomes after liver transplantation in the model for end-stage liver disease era.终末期肝病模型时代肝移植后的肾脏结局
Liver Transpl. 2009 Sep;15(9):1142-8. doi: 10.1002/lt.21821.
5
Patterns of Kidney Function Before and After Orthotopic Liver Transplant: Associations With Length of Hospital Stay, Progression to End-Stage Renal Disease, and Mortality.原位肝移植前后肾功能模式:与住院时间、进展为终末期肾病和死亡率的关系。
Transplantation. 2015 Dec;99(12):2556-64. doi: 10.1097/TP.0000000000000767.
6
Renal outcomes of simultaneous liver-kidney transplantation compared to liver transplant alone for candidates with renal dysfunction.对于合并肾功能不全的患者,肝肾联合移植与单纯肝移植相比的肾脏预后。
Clin Transplant. 2015 Jan;29(1):34-43. doi: 10.1111/ctr.12479. Epub 2014 Nov 17.
7
Risk of end-stage renal disease among liver transplant recipients with pretransplant renal dysfunction.肝移植受者移植前肾功能障碍与终末期肾病风险。
Am J Transplant. 2012 Nov;12(11):2958-65. doi: 10.1111/j.1600-6143.2012.04177.x. Epub 2012 Jul 3.
8
The changing impact of pre-liver transplant renal dysfunction on post-transplant survival: results of 2 decades from a single center.肝移植前肾功能障碍对移植后生存的影响变化:单中心 20 年的结果。
Ann Hepatol. 2021 Sep-Oct;24:100317. doi: 10.1016/j.aohep.2021.100317. Epub 2021 Feb 3.
9
Cardiovascular Disease Outcomes Related to Early Stage Renal Impairment After Liver Transplantation.肝移植后早期肾功能损害与心血管疾病结局的关系。
Transplantation. 2018 Jul;102(7):1096-1107. doi: 10.1097/TP.0000000000002175.
10
Liver Transplant Recipients With End-Stage Renal Disease Largely Benefit From Kidney Transplantation.患有终末期肾病的肝移植受者在很大程度上受益于肾移植。
Transplant Proc. 2018 Jan-Feb;50(1):202-210. doi: 10.1016/j.transproceed.2017.11.009.

引用本文的文献

1
Tracking the trajectory of kidney dysfunction in cirrhosis: the acute kidney injury: chronic kidney disease spectrum.追踪肝硬化患者肾功能不全的轨迹:急性肾损伤-慢性肾病谱
Clin Mol Hepatol. 2025 Jul;31(3):730-752. doi: 10.3350/cmh.2024.1060. Epub 2025 Mar 26.
2
[Anesthesia for organ transplant patients].[器官移植患者的麻醉]
Anaesthesiologie. 2023 Nov;72(11):773-783. doi: 10.1007/s00101-023-01332-x. Epub 2023 Oct 24.
3
Recent advances in pathophysiology, diagnosis and management of hepatorenal syndrome: A review.
肝肾综合征病理生理学、诊断及治疗的最新进展:综述
World J Hepatol. 2023 Jun 27;15(6):741-754. doi: 10.4254/wjh.v15.i6.741.
4
Hepatorenal syndrome: Current concepts and future perspectives.肝肾综合征:当前概念与未来展望。
Clin Mol Hepatol. 2023 Oct;29(4):891-908. doi: 10.3350/cmh.2023.0024. Epub 2023 Apr 13.
5
A Systematic Review of the Literature on Chronic Kidney Disease Following Liver Transplantation.肝移植后慢性肾脏病的文献系统评价。
Ann Transplant. 2022 May 24;27:e935170. doi: 10.12659/AOT.935170.